Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -500 | -100.0% | -1.26% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -6,199 | -100.0% | -4.76% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -2,600 | -100.0% | -5.09% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -15,900 | -100.0% | -5.17% | – |
TSRO | Exit | TESARO INC | $0 | – | -10,000 | -100.0% | -6.27% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -13,310 | -100.0% | -6.68% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -14,200 | -100.0% | -7.79% | – |
JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -13,000 | -100.0% | -9.61% | – |
PETX | Exit | ARATANA THERAPEUTICS INC | $0 | – | -218,515 | -100.0% | -12.79% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -72,723 | -100.0% | -14.47% | – |
EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -34,611 | -100.0% | -26.11% | – |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 12 | Q3 2016 | 14.4% |
LILLY ELI & CO | 12 | Q3 2016 | 20.0% |
ALEXION PHARMACEUTICALS INC | 11 | Q3 2016 | 15.1% |
MALLINCKRODT PUB LTD CO | 8 | Q3 2015 | 7.0% |
UNITED THERAPEUTICS CORP DEL | 7 | Q3 2015 | 11.7% |
REGENERON PHARMACEUTICALS | 7 | Q3 2016 | 14.6% |
UNIVERSAL HLTH SVCS INC | 7 | Q2 2015 | 12.1% |
ZOETIS INC | 7 | Q3 2016 | 5.2% |
INCYTE CORP | 6 | Q4 2015 | 14.7% |
EDWARDS LIFESCIENCES CORP | 5 | Q3 2016 | 28.5% |
View March Altus Capital Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2016-11-07 |
13F-HR | 2016-07-27 |
13F-HR | 2016-05-12 |
13F-HR | 2016-02-16 |
13F-HR | 2015-11-16 |
13F-HR | 2015-08-14 |
13F-HR | 2015-05-15 |
13F-HR | 2015-02-17 |
13F-HR | 2014-11-14 |
13F-HR | 2014-08-14 |
View March Altus Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.